Diagnostics

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

Dxcover's new AI platform uses infrared light to detect early-stage colorectal, pancreatic, and ovarian cancers from blood with unprecedented sensitivity.

OneLegacy launches a massive campaign to address SoCal's organ shortage, where 20,000 wait for a second chance at life. Here's how you can help.

A new partnership brings FDA-cleared eye-tracking tech to more providers, promising to cut year-long waits for autism diagnosis to mere minutes.

For a second year, ABA Centers ranks among the Americas' fastest-growing firms, tackling the autism care crisis with a disruptive, no-waitlist model.

A pivotal clinical trial for PMM2-CDG, a devastating genetic disorder with no approved treatments, has completed enrollment, offering hope to thousands.

Dr. Amit Singal, a leading hepatologist, joins Curve Biosciences as CMO, aiming to leverage AI to find chronic liver disease before it becomes incurable.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

A new $3M grant program targets the immune system's role in neurodegeneration, funding bold new research to combat Alzheimer's and Parkinson's.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.

New platform combines genetic, epigenetic, and lab tests with AI and coaching, aiming to simplify personal health in a crowded and cautious market.

As cancer strikes younger patients, a new partnership aims to find the disease before symptoms start. But is this new technology ready for prime time?

Fleming College invests $100,000 in new entrance scholarships to ease student financial burdens and address Ontario's critical skilled labor shortages.

A Virginia pilot program offers free clinical-grade bloodwork with donations, aiming to reverse a 40% drop in young donors and empower the uninsured.

A new CMS pilot program allows CBD for Medicare patients at no cost, sparking a race among suppliers like High Tide's NuLeaf Naturals to enter the market.

As Stryker preps its Q1 2026 report, all eyes are on whether the MedTech giant can sustain its momentum amid new products and industry-wide pressures.

A breakthrough test for Parkinson's is expanding worldwide, promising earlier, more accurate diagnoses and accelerating the hunt for a cure.

Bebird's new EarSight Ultra offers 5G and a 2K camera for at-home ear care, but medical experts warn of the risks of self-diagnosis and injury.

A stark new benchmark study reveals poor survival in late-stage GvHD, just as MaaT Pharma’s microbiome therapy shows dramatically better outcomes.

The Our Health Our Wellness campaign aims to close critical health disparity gaps with resources, events, and education for underserved communities.